News Search

Dr. Joshua Kantrowitz leads study that links hearing deficiencies in people with schizophrenia to dysfunction in NMDA brain receptors.

Dr. Catherine Clelland and colleagues find a drug prescribed to many patients with schizophrenia or bipolar disorder may decrease negative symptoms for people with a certain variant of the COMT gene.

The Irving Institute appointed José A. Luchsinger-Stuart, MD, MPH, as Director of the Community Engagement Core Resource (CECR), as of June 2016.

The five-year grant from the National Center for Advancing Translational Sciences at the NIH is part of a multidisciplinary effort to speed the discovery and development of new medical therapies.